Lannett Company (LCI) was Initiated by Deutsche Bank to “Hold” and the brokerage firm has set the Price Target at $26. Deutsche Bank advised their investors in a research report released on Jun 29, 2016.
On the company’s financial health, Lannett Company reported $0.75 EPS for the quarter, beating the analyst consensus estimate by $ 0.12 according to the earnings call on May 3, 2016. Analyst had a consensus of $0.63. The company had revenue of $163.70 million for the quarter, compared to analysts expectations of $161.62 million. The company’s revenue was up 64.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.97 EPS.
Lannett Company closed down -1.41 points or -5.82% at $22.82 with 7,11,784 shares getting traded on Monday. Post opening the session at $24.14, the shares hit an intraday low of $22.6 and an intraday high of $24.27 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
In a different news, on Jun 24, 2016, Robert Ehlinger (VP and CIO) sold 37,141 shares at $25.07 per share price. According to the SEC, on Feb 8, 2016, Albert Iii Paonessa (director) purchased 2,500 shares at $24.57 per share price. On Feb 8, 2016, Martin P Galvan (CFO) purchased 3,000 shares at $24.65 per share price, according to the Form-4 filing with the securities and exchange commission.
Lannett Company Inc. develops manufactures markets and distributes generic versions of brand pharmaceutical products. The Company’s products include Levothyroxine Sodium tablets Digoxin tablets Butalbital products Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products such as Cocaine Topical Solution (C-Topical) Morphine Sulfate Oral Solution Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.